PGSGX
Price
$18.95
Change
+$0.05 (+0.26%)
Updated
Dec 2 closing price
Net Assets
2.88B
VISGX
Price
$84.55
Change
-$0.02 (-0.02%)
Updated
Dec 2 closing price
Net Assets
39.74B
Interact to see
Advertisement

PGSGX vs VISGX

Header iconPGSGX vs VISGX Comparison
Open Charts PGSGX vs VISGXBanner chart's image
JPMorgan Small Cap Growth A
Price$18.95
Change+$0.05 (+0.26%)
VolumeN/A
Net Assets2.88B
Vanguard Small Cap Growth Index I
Price$84.55
Change-$0.02 (-0.02%)
VolumeN/A
Net Assets39.74B
PGSGX vs VISGX Comparison Chart in %
View a ticker or compare two or three
VS
PGSGX vs. VISGX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGSGX is a StrongBuy and VISGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 39.7B vs. PGSGX (2.88B). PGSGX pays higher dividends than VISGX: PGSGX (0.54) vs VISGX (0.43). PGSGX was incepted earlier than VISGX: PGSGX (34 years) vs VISGX (28 years). PGSGX (1.26) is less costly to investors than VISGX (0.19). PGSGX is a more actively managed with annual turnover of: 48.00 vs. VISGX (21.00). PGSGX has a lower initial minimum investment than VISGX: PGSGX (1000) vs VISGX (3000). VISGX annual gain was more profitable for investors over the last year : 0.13 vs. PGSGX (-1.19). VISGX return over 5 years is better than : 21.65 vs. PGSGX (-24.76).
PGSGXVISGXPGSGX / VISGX
Total Expense Ratio1.240.19653%
Annual Report Gross Expense Ratio1.260.19663%
Fund Existence34 years28 years-
Gain YTD6.5997.51388%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets2.88B39.7B7%
Annual Yield % from dividends0.540.43125%
Returns for 1 year-1.190.13-924%
Returns for 3 years26.7439.8467%
Returns for 5 years-24.7621.65-114%
Returns for 10 years42.69145.1629%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOFX48.34N/A
N/A
Patient Opportunity FI
MENYX9.51N/A
N/A
Madison Covered Call & Equity Income Y
JMCGX30.61N/A
N/A
Jacob Discovery Fd Inv
HFQIX7.21N/A
N/A
Janus Henderson Global Equity Income I
JRSDX13.01N/A
N/A
JH Adaptive Risk Mgd U.S. Eq D